chrX-152649297-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_018558.4(GABRQ):āc.574A>Gā(p.Met192Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000228 in 1,184,483 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018558.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRQ | NM_018558.4 | c.574A>G | p.Met192Val | missense_variant | 5/9 | ENST00000598523.3 | NP_061028.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRQ | ENST00000598523.3 | c.574A>G | p.Met192Val | missense_variant | 5/9 | 1 | NM_018558.4 | ENSP00000469332.1 | ||
MAGEA3-DT | ENST00000671457.1 | n.130-9503T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 11AN: 111437Hom.: 0 Cov.: 23 AF XY: 0.0000594 AC XY: 2AN XY: 33647
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183526Hom.: 0 AF XY: 0.0000294 AC XY: 2AN XY: 67954
GnomAD4 exome AF: 0.0000149 AC: 16AN: 1073046Hom.: 0 Cov.: 25 AF XY: 0.0000147 AC XY: 5AN XY: 340846
GnomAD4 genome AF: 0.0000987 AC: 11AN: 111437Hom.: 0 Cov.: 23 AF XY: 0.0000594 AC XY: 2AN XY: 33647
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.574A>G (p.M192V) alteration is located in exon 5 (coding exon 5) of the GABRQ gene. This alteration results from a A to G substitution at nucleotide position 574, causing the methionine (M) at amino acid position 192 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at